Healthcare US R&D 300: Quarterly Rankings

  • ID: 4451062
  • Report
  • 213 pages
  • FinGlobe, Inc
1 of 3

The healthcare sector is spending an increasing amount on medical and health research and development. With most of the healthcare companies engaged substantially and continuously in R&D, a ranking can provide a clearer picture of their comparative R&D performance. This report offered provides such rankings of leading healthcare companies of United States based on their research and development focus that will enable investors, analysts, regulators, and market competitors to identify the top R&D intensive healthcare companies of United States.

Key Features of the report:

  • 1000 global healthcare companies comprehensively analyzed to identify top 300 R&D intensive companies of United States
  • Ranking methodology objective and purely R&D-based
  • Selected top 300 R&D intensive companies of United States analyzed by sub-industry, and market capitalization group; as well as from various other perspectives
  • Selected R&D 300 companies of United States segregated into three modules of 100 companies each
  • Rankings based on R&D expenses, R&D expenses as % of total sales, R&D expenses growth, R&D expenses Q-o-Q changes, and cumulative R&D performance assigned to 100 companies included in each module
  • Rankings based on recent four quarters’ data
  • Rankings presented by ranks,company name and sub-industry
  • 100 companies included in each module also analyzed from various other perspectives

Report useful to:

  • Investors looking for emerging investing opportunities
  • Analysts in search of healthy portfolios
  • Healthcare firms seeking new partners for collaborations
  • Healthcare executives assessing their competitors’ R&D growth
  • Service providers to identify new business opportunities
  • Market competitors to identify leading R&D intensive firms
READ MORE
Note: Product cover images may vary from those shown
2 of 3

Introduction

Research Methodology

Chapter 1: Identification of 500 Companies from Healthcare R&D Input Data set

1.1 Frequency Chart: By market capitalization group
1.2 Frequency Chart: By sub-industry within healthcare sector

Chapter 2: Rankings of R&D Healthcare 300 Companies of United States

2.1 By R&D expenses
2.2 By R&D expenses to total sales
2.3 By R&D expenses growth
2.4 By R&D expenses Q-o-Q changes
2.5 By cumulative R&D ranks
2.6 By R&D expenses weight age

Chapter 3: Analysis of R&D Healthcare 300 Companies of United States

3.1 Major 10 gainers and decliners in R&D in Q1-2017 vs. Q4-2016
3.2 Companies dropped from and added to R&D healthcare 300 companies of United States in Q1-2017
3.3 Peer analysis for R&D investment
3.4 R&D news vs. R&D ranks

Chapter 4: Summary and Conclusions

Appendices

Appendix 1 List of R&D healthcare 300 companies of United States: By company name
Appendix 2 List of R&D healthcare 300 companies of United States: By sub-industry and company name

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll